[EN] TETRAHYDROISOQUINOLINE COMPOUNDS AS NRF2 ACTIVATORS<br/>[FR] COMPOSÉS DE TÉTRAHYDROISOQUINOLÉINE UTILISÉS EN TANT QU'ACTIVATEURS DE NRF2
申请人:C4X DISCOVERY LTD
公开号:WO2021214470A1
公开(公告)日:2021-10-28
The present invention relates to compounds that are Nrf2 activators. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with Nrf2 activation.
Hydrogenation reactions of some [1,2,3]triazolo[1,5-a]pyridines and their benzo derivatives, [1,2,3]-triazolo[1,5-a]quinoline and [1,2,3]triazolo[5,1-a]isoquinoline are studied. In general, the pyridinering is more easily hydrogenated than the triazole or benzenerings.
某些[1,2,3]三唑并[1,5- a ]吡啶及其苯并衍生物,[1,2,3]-三唑并[1,5- a ]喹啉和[1,2,3]的氢化反应研究了三唑并[5,1- a ]异喹啉。通常,吡啶环比三唑或苯环更容易氢化。